Representing an investment of more than 50 million euros, this new unit dedicated to the bioproduction of pharmaceutical-grade hyaluronic acid represents a pivotal stage in the development of HTL and the largest investment ever made in the world for a biopolymer production unit.
It will enable HTL to become the largest producer of pharmaceutical-grade hyaluronic acid in the world and accelerate its international development.
Read more below.
news from us
Articles February 10, 2024
Happy Lunar New Year 2024 !
As we step into the Year of the Dragon, we extend our warmest wishes to all our colleagues, clients, partners, and friends celebrating this joyous occasion.
Articles February 3, 2024
HTL Biotechnology at IMCAS world congress 2024
IMCAS, the world’s leading congress dedicated to dermatology, plastic surgery and aesthetics.
Articles January 17, 2024
HTL Biotechnology will be at IMCAS 2024 !
We are excited to announce that we will be participating in the IMCAS 2024 Congress !
Join us for an immersive scientific program with innovation at its core, and network with the world’s leading figures and experts in dermatology and aesthetics.
We can’t wait to see you there !